Search results
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 7 hours agoThe news sent Novavax stock more than 2% higher to 21.40 in morning trades. On Wednesday, Novavax...
F.D. Flam: Americans need COVID closure. Congress blew its chance
Roanoke Times· 7 hours agoCongress blew its chance recently to give Americans some insight into the COVID pandemic that...
F.D. Flam: Americans need COVID closure. Congress blew its chance
Waterloo-Cedar Falls Courier· 7 hours agoCongress blew its chance recently to give Americans some insight into the COVID pandemic that...
F.D. Flam: Americans need COVID closure. Congress blew its chance
Southwest Iowa's daily newspaper· 7 hours agoCongress blew its chance recently to give Americans some insight into the COVID pandemic that...
F.D. Flam: Americans need COVID closure. Congress blew its chance
The Fredericksburg Free Lance-Star· 7 hours agoCongress blew its chance recently to give Americans some insight into the COVID pandemic that...
Trending tickers: Berkshire Hathaway, Nvidia, Novavax and Adani Enterprises
Yahoo Finance UK· 2 days agoShares soared 21% during the last session and were still pushing higher in pre-market trading, after...
CONLEY COMMENTARY: Dr. Fauci’s Admission
WSAU Wausau· 2 days agoCONLEY COMMENTARY (WSAU) - I had an unusual reason for not wanting the COVID vaccine. I tested positive twice ...
Los Angeles could end COVID vaccination rule for city employees
Los Angeles Times· 6 days agoLos Angeles could soon end its requirement for city employees to be vaccinated against COVID-19....
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 2 days agoIn the trials, she gives two shots two weeks apart to prime the immune system, a third two months...
Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid
CBC via Yahoo News· 2 days agoWhen Greg Pletz contracted COVID-19 in mid-May, he called the Saskatchewan 811 HealthLine and was...